These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22215265)

  • 21. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
    Clarke PM; Gray AM; Briggs A; Farmer AJ; Fenn P; Stevens RJ; Matthews DR; Stratton IM; Holman RR;
    Diabetologia; 2004 Oct; 47(10):1747-59. PubMed ID: 15517152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data.
    Leal J; Reed SD; Patel R; Rivero-Arias O; Li Y; Schulman KA; Califf RM; Holman RR; Gray AM
    Diabetes Care; 2020 Oct; 43(10):2485-2492. PubMed ID: 32796009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications.
    J Hypertens; 1993 Mar; 11(3):309-17. PubMed ID: 8387089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes.
    O'Connor PJ; Vazquez-Benitez G; Schmittdiel JA; Parker ED; Trower NK; Desai JR; Margolis KL; Magid DJ
    Diabetes Care; 2013 Feb; 36(2):322-7. PubMed ID: 22966094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics.
    Logan AG; Irvine MJ; McIsaac WJ; Tisler A; Rossos PG; Easty A; Feig DS; Cafazzo JA
    Hypertension; 2012 Jul; 60(1):51-7. PubMed ID: 22615116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
    Valentine WJ; Bottomley JM; Palmer AJ; Brändle M; Foos V; Williams R; Dormandy JA; Yates J; Tan MH; Massi-Benedetti M;
    Diabet Med; 2007 Sep; 24(9):982-1002. PubMed ID: 17593245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of Quality-Adjusted Life Expectancy of Patients With Oral Cancer: Integration of Lifetime Survival With Repeated Quality-of-Life Measurements.
    Chung CH; Hu TH; Wang JD; Hwang JS
    Value Health Reg Issues; 2020 May; 21():59-65. PubMed ID: 31655464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control.
    Diabetologia; 1996 Dec; 39(12):1554-61. PubMed ID: 8960842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. United Kingdom Prospective Diabetes Study (UKPDS). Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus.
    Nasr CE; Hoogwerf BJ; Faiman C; Reddy SS
    Cleve Clin J Med; 1999 Apr; 66(4):247-53. PubMed ID: 10199061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000.
    Imperatore G; Cadwell BL; Geiss L; Saadinne JB; Williams DE; Ford ES; Thompson TJ; Narayan KM; Gregg EW
    Am J Epidemiol; 2004 Sep; 160(6):531-9. PubMed ID: 15353413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study.
    Xu W; Goldberg SI; Shubina M; Turchin A
    BMJ; 2015 Feb; 350():h158. PubMed ID: 25655523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical claim cost impact of improved diabetes control for medicare and commercially insured patients with type 2 diabetes.
    Fitch K; Pyenson BS; Iwasaki K
    J Manag Care Pharm; 2013 Oct; 19(8):609-20, 620a-620d. PubMed ID: 24074007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L; Poulter NR; Sever PS; Colhoun HM; Livingstone SJ; Boekholdt SM; Pressel SL; Davis BR; van der Graaf Y; Visseren FL;
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP; Svärdsudd K; Andersson DK
    Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure control among type 2 diabetics.
    Al-Shehri AM
    Saudi Med J; 2008 May; 29(5):718-22. PubMed ID: 18454221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial.
    Anderson RJ; Bahn GD; Moritz TE; Kaufman D; Abraira C; Duckworth W;
    Diabetes Care; 2011 Jan; 34(1):34-8. PubMed ID: 21059830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy.
    Hoerger TJ; Zhang P; Segel JE; Gregg EW; Narayan KM; Hicks KA
    Diabetes Res Clin Pract; 2009 Dec; 86(3):225-32. PubMed ID: 19833403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients.
    Sundström J; Sheikhi R; Ostgren CJ; Svennblad B; Bodegård J; Nilsson PM; Johansson G
    J Hypertens; 2013 Aug; 31(8):1603-10. PubMed ID: 23625112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.